Orthofix International N.V. (NASDAQ:OFIX) Stake Raised by TIAA CREF Investment Management LLC

TIAA CREF Investment Management LLC boosted its position in Orthofix International N.V. (NASDAQ:OFIX) by 15.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 136,076 shares of the medical device company’s stock after buying an additional 18,506 shares during the period. TIAA CREF Investment Management LLC owned about 0.76% of Orthofix International N.V. worth $5,191,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Dimensional Fund Advisors LP increased its position in shares of Orthofix International N.V. by 3.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 759,298 shares of the medical device company’s stock valued at $27,471,000 after buying an additional 26,114 shares in the last quarter. Wellington Management Group LLP bought a new stake in shares of Orthofix International N.V. during the first quarter valued at approximately $20,021,000. Ameriprise Financial Inc. boosted its stake in shares of Orthofix International N.V. by 23.5% in the first quarter. Ameriprise Financial Inc. now owns 423,655 shares of the medical device company’s stock valued at $16,162,000 after buying an additional 80,710 shares during the last quarter. State Street Corp boosted its stake in shares of Orthofix International N.V. by 5.6% in the fourth quarter. State Street Corp now owns 364,267 shares of the medical device company’s stock valued at $13,179,000 after buying an additional 19,395 shares during the last quarter. Finally, Gabelli Funds LLC boosted its stake in shares of Orthofix International N.V. by 0.3% in the first quarter. Gabelli Funds LLC now owns 291,450 shares of the medical device company’s stock valued at $11,119,000 after buying an additional 1,000 shares during the last quarter.

Shares of Orthofix International N.V. (OFIX) opened at 45.96 on Thursday. The firm’s 50-day moving average price is $44.99 and its 200-day moving average price is $39.85. Orthofix International N.V. has a 52-week low of $32.51 and a 52-week high of $48.25. The stock’s market cap is $829.30 million.

Orthofix International N.V. (NASDAQ:OFIX) last released its quarterly earnings data on Thursday, May 4th. The medical device company reported $0.27 EPS for the quarter, hitting analysts’ consensus estimates of $0.27. Orthofix International N.V. had a negative net margin of 0.82% and a positive return on equity of 10.03%. The firm had revenue of $102.70 million during the quarter, compared to the consensus estimate of $97.17 million. During the same quarter in the previous year, the company posted $0.28 earnings per share. The firm’s revenue was up 4.1% on a year-over-year basis. Equities analysts predict that Orthofix International N.V. will post $1.53 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by BBNS and is the sole property of of BBNS. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://baseballnewssource.com/markets/orthofix-international-n-v-nasdaqofix-stake-raised-by-tiaa-cref-investment-management-llc/1234359.html.

Several brokerages have recently issued reports on OFIX. SunTrust Banks, Inc. initiated coverage on shares of Orthofix International N.V. in a research report on Tuesday, May 23rd. They set a “buy” rating and a $49.00 target price on the stock. Ladenburg Thalmann Financial Services initiated coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. They set a “buy” rating and a $53.25 price objective on the stock. Zacks Investment Research cut Orthofix International N.V. from a “hold” rating to a “sell” rating in a research report on Tuesday, May 9th. BTIG Research began coverage on Orthofix International N.V. in a research report on Wednesday, June 21st. They set a “buy” rating and a $52.00 target price on the stock. Finally, Langenberg & Company restated a “buy” rating and set a $53.25 target price on shares of Orthofix International N.V. in a research report on Wednesday, June 14th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Orthofix International N.V. has a consensus rating of “Buy” and a consensus price target of $51.30.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with our FREE daily email newsletter.

 


Latest News

Todd Frazier Traded to Yankees for Blake Rutherford and Others
Todd Frazier Traded to Yankees for Blake Rutherford and Others
Tigers Would Include Cash in Verlander Deal and Other MLB Trade Rumors
Tigers Would Include Cash in Verlander Deal and Other MLB Trade Rumors
Todd Frazier Trade to Boston Appears to Be Decided
Todd Frazier Trade to Boston Appears to Be Decided
Chicago White Sox Continue Rebuild Without Jose Quintana
Chicago White Sox Continue Rebuild Without Jose Quintana
Mike Trout Returns from Injury With Single and Stole Base
Mike Trout Returns from Injury With Single and Stole Base
Chicago Cubs Strengthen Rotation Through Trade for Jose Quintana
Chicago Cubs Strengthen Rotation Through Trade for Jose Quintana


Leave a Reply

 
© 2006-2017 BBNS.